Literature DB >> 6197998

A difference infrared spectroscopic study of gramicidin A, alamethicin and bacteriorhodopsin in perdeuterated dimyristoylphosphatidylcholine.

D C Lee, A A Durrani, D Chapman.   

Abstract

Difference infrared spectroscopy has been used to study the way in which the intrinsic molecules gramicidin A, alamethicin and bacteriorhodopsin perturb their environment when present within a lipid bilayer structure. Dimyristoylphosphatidylcholine containing perdeuterated chains has been used to enable the lipid chain C-2H stretching absorption band to be separated from the C-H bands arising from the intrinsic polypeptide or protein. The C-2H stretching bands of the phospholipid are sensitive to two different types of chain conformation. The C-2H stretching frequency provides information about the static order of the lipid chains, whilst the half-maximum bandwidth provides a measure of chain librational and torsional motion. From the measurements it is concluded that: (1) Above the lipid phase transition temperature tc, low concentrations of either gramicidin A or alamethicin cause a small decrease in lipid chain gauche isomers whilst bacteriorhodopsin in the lipid bilayer has no effect. At higher concentrations each intrinsic molecule causes an increase to occur in lipid chain gauche isomers. (2) The lipid acyl chain motion, as deduced from the bandwidths is increased by the presence of a low concentration of gramicidin A within the lipid bilayer. The presence of the other intrinsic molecules studied have little effect. A higher concentration of alamethicin causes a decrease in chain motion whilst gramicidin A and bacteriorhodopsin have no effect. (3) Below tc each of the intrinsic molecules when present in the lipid bilayer causes an increase in gauche isomers to occur as well as an increase in the lipid chain motion. A broadening of the lipid phase transition occurs as the concentration of the polypeptide increases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197998     DOI: 10.1016/0005-2736(84)90008-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Direct visualization of asymmetric behavior in supported lipid bilayers at the gel-fluid phase transition.

Authors:  Z Vivian Feng; Tighe A Spurlin; Andrew A Gewirth
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

Review 2.  Gramicidin A--phospholipid model systems.

Authors:  B Cornell
Journal:  J Bioenerg Biomembr       Date:  1987-12       Impact factor: 2.945

3.  The effect of gramicidin A on phospholipid bilayers.

Authors:  B A Cornell; L E Weir; F Separovic
Journal:  Eur Biophys J       Date:  1988       Impact factor: 1.733

4.  A model for gramicidin A'-phospholipid interactions in bilayers.

Authors:  B A Cornell; F Separovic
Journal:  Eur Biophys J       Date:  1988       Impact factor: 1.733

Review 5.  New biophysical techniques and their application to the study of membranes.

Authors:  D Chapman; J A Hayward
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

6.  A difference infrared-spectroscopic study of the interaction of ubiquinone-10 with phospholipid bilayers.

Authors:  M Ondarroa; P J Quinn
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

7.  Electron-spin resonance study of aggregation of gramicidin in dipalmitoylphosphatidylcholine bilayers and hydrophobic mismatch.

Authors:  M Ge; J H Freed
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

8.  Solvent history dependence of gramicidin-lipid interactions: a Raman and infrared spectroscopic study.

Authors:  M Bouchard; M Auger
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

9.  An electron spin resonance study of interactions between gramicidin A' and phosphatidylcholine bilayers.

Authors:  M Ge; J H Freed
Journal:  Biophys J       Date:  1993-11       Impact factor: 4.033

Review 10.  Model ion channels: gramicidin and alamethicin.

Authors:  G A Woolley; B A Wallace
Journal:  J Membr Biol       Date:  1992-08       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.